CALU expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.122800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.893800E-01
Normal-vs-Stage2
3.487000E-01
Normal-vs-Stage3
6.540200E-01
Normal-vs-Stage4
2.805600E-01
Stage1-vs-Stage2
1.808800E-01
Stage1-vs-Stage3
4.751000E-01
Stage1-vs-Stage4
9.725600E-02
Stage2-vs-Stage3
7.014800E-01
Stage2-vs-Stage4
4.323000E-01
Stage3-vs-Stage4
4.791000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.253600E-01
Normal-vs-AfricanAmerican
3.286800E-01
Normal-vs-Asian
6.126000E-01
Caucasian-vs-AfricanAmerican
8.084200E-01
Caucasian-vs-Asian
5.578000E-01
AfricanAmerican-vs-Asian
5.062200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.814000E-01
Normal-vs-Female
3.237400E-01
Male-vs-Female
5.657400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.837800E-01
Normal-vs-Age(41-60Yrs)
1.829580E-01
Normal-vs-Age(61-80Yrs)
5.137600E-01
Normal-vs-Age(81-100Yrs)
6.175400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.028790E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.673000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.595800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.537700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.247000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.500800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.645000E-01
Normal-vs-Daily Drinker
8.266800E-01
Normal-vs-Weekly Drinker
2.072200E-01
Normal-vs-Occasional Drinker
4.986000E-01
Normal-vs-Social Drinker
4.133400E-01
Non Drinker-vs-Daily Drinker
8.961400E-01
Non Drinker-vs-Weekly Drinker
2.596100E-02
Non Drinker-vs-Occasional Drinker
2.262800E-01
Non Drinker-vs-Social Drinker
1.382170E-01
Daily Drinker-vs-Weekly Drinker
2.506000E-02
Daily Drinker-vs-Occasional Drinker
2.140600E-01
Daily Drinker-vs-Social Drinker
1.313040E-01
Weekly Drinker-vs-Occasional Drinker
3.385000E-01
Weekly Drinker-vs-Social Drinker
6.876000E-01
Occasional Drinker-vs-Social Drinker
6.435600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.061800E-01
Normal-vs-Grade 2
8.617800E-01
Normal-vs-Grade 3
8.777400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.765000E-04
Grade 1-vs-Grade 3
9.140500E-03
Grade 1-vs-Grade 4
7.061800E-01
Grade 2-vs-Grade 3
7.903400E-01
Grade 2-vs-Grade 4
8.617800E-01
Grade 3-vs-Grade 4
8.777400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.343400E-01
Normal-vs-NonDiabetic
4.411000E-01
Diabetic-vs-NonDiabetic
8.730600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.652800E-01
Normal-vs-NoPancreatitis
4.595400E-01
Pancreatitis-vs-NoPancreatitis
7.763800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.022000E-01
Normal-vs-N1
3.163600E-01
N0-vs-N1
2.613200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.836200E-01
Normal-vs-TP53-NonMutant
8.263000E-01
TP53-Mutant-vs-TP53-NonMutant
5.056700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
